Monofer (iron isomaltoside 1000)

DRUG2 trials

Sponsors

Pharmacosmos A/S, Hull University Teaching Hospitals NHS Trust

Conditions

AnaemiaInflammatory Bowel DiseaseIron Deficiency, AnaemiaPeritoneal Dialysis

Phase 1

Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease

CompletedNCT01213680

Pharmacosmos A/SInflammatory Bowel Disease

Start: 2012-02-29End: 2012-11-30Updated: 2013-11-14

Phase 3

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

RecruitingNCT06884280

Hull University Teaching Hospitals NHS TrustAnaemia, Iron Deficiency, Anaemia, Peritoneal Dialysis

Start: 2025-11-13End: 2027-10-01Target: 30Updated: 2026-03-17